Full-Length Soluble Urokinase Plasminogen Activator Receptor Down-Modulates Nephrin Expression in Podocytes

Scientific Reports - United Kingdom
doi 10.1038/srep13647
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea

Medicina
Medicine
2020English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans With CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)

Science-Business eXchange
2013English

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Are Elevated in Severe Pre-Eclampsia

Journal of Clinical Gynecology and Obstetrics
2016English

Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD

2015English

Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2015English

Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Focal Segmental Glomerulosclerosis; A Retrospective Analysis

Journal of Nephropathology
Nephrology
2018English

Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor‐1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy